ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-19U14299
Home | Market Reports | Health| Vision Care
Global Age Related Macular Degeneration AMD Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Age-Related Macular Degeneration (AMD) Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-19U14299
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Bausch Health Companies Inc.
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc

Age-Related Macular Degeneration (AMD) Therapeutics Market Size

The global Age-Related Macular Degeneration (AMD) Therapeutics market is projected to grow from US$ 8129 million in 2024 to US$ 11400 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Age-Related Macular Degeneration (AMD) Therapeutics Market

Age-Related Macular Degeneration (AMD) Therapeutics Market

Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
Market Analysis and Insights: Global Age-Related Macular Degeneration (AMD) Therapeutics Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Age-Related Macular Degeneration (AMD) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Age-Related Macular Degeneration (AMD) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Age-Related Macular Degeneration (AMD) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Age-Related Macular Degeneration (AMD) Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Age-Related Macular Degeneration (AMD) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Age-Related Macular Degeneration (AMD) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Age-Related Macular Degeneration (AMD) Therapeutics Market Report

Report Metric Details
Report Name Age-Related Macular Degeneration (AMD) Therapeutics Market
Accounted market size in 2024 US$ 8129 million
Forecasted market size in 2030 US$ 11400 million
CAGR 5.8
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Wet AMD
  • Dry AMD
Segment by Application
  • Hospital
  • Clinic
  • Research Institute
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen Inc., Bausch Health Companies, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Age-Related Macular Degeneration (AMD) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Age-Related Macular Degeneration (AMD) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Age-Related Macular Degeneration (AMD) Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Age-Related Macular Degeneration (AMD) Therapeutics Market growing?

Ans: The Age-Related Macular Degeneration (AMD) Therapeutics Market witnessing a CAGR of 5.8 during the forecast period 2025-2030.

What is the Age-Related Macular Degeneration (AMD) Therapeutics Market size in 2030?

Ans: The Age-Related Macular Degeneration (AMD) Therapeutics Market size in 2030 will be US$ 11400 million.

Who are the main players in the Age-Related Macular Degeneration (AMD) Therapeutics Market report?

Ans: The main players in the Age-Related Macular Degeneration (AMD) Therapeutics Market are Amgen Inc., Bausch Health Companies, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc.

What are the Application segmentation covered in the Age-Related Macular Degeneration (AMD) Therapeutics Market report?

Ans: The Applications covered in the Age-Related Macular Degeneration (AMD) Therapeutics Market report are Hospital, Clinic, Research Institute, Other

What are the Type segmentation covered in the Age-Related Macular Degeneration (AMD) Therapeutics Market report?

Ans: The Types covered in the Age-Related Macular Degeneration (AMD) Therapeutics Market report are Wet AMD, Dry AMD

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2019-2030)
2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Region
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Dynamics
2.3.1 Age-Related Macular Degeneration (AMD) Therapeutics Industry Trends
2.3.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Drivers
2.3.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
2.3.4 Age-Related Macular Degeneration (AMD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Age-Related Macular Degeneration (AMD) Therapeutics by Players
3.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
3.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2023
3.5 Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics Head office and Area Served
3.6 Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Product and Application
3.7 Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Type
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2025-2030)
5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2019-2030)
6.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
6.2.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
6.3.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
6.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2019-2030)
7.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
7.2.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
7.3.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
7.4.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2019-2030)
8.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
8.2.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024)
8.2.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030)
8.2.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
8.3.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024)
8.3.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030)
8.3.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2019-2030)
9.2 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
9.2.1 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
9.3 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
9.3.1 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
9.4 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
9.4.1 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
11.1.5 Amgen Inc. Recent Developments
11.2 Bausch Health Companies, Inc.
11.2.1 Bausch Health Companies, Inc. Company Details
11.2.2 Bausch Health Companies, Inc. Business Overview
11.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
11.2.5 Bausch Health Companies, Inc. Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Regeneron Pharmaceuticals Inc.
11.5.1 Regeneron Pharmaceuticals Inc. Company Details
11.5.2 Regeneron Pharmaceuticals Inc. Business Overview
11.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
11.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
11.5.5 Regeneron Pharmaceuticals Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Amgen Inc
Bausch Health Companies Inc.
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc
List of Tables
    Table 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Wet AMD
    Table 3. Key Players of Dry AMD
    Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Region (2025-2030)
    Table 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Trends
    Table 11. Age-Related Macular Degeneration (AMD) Therapeutics Market Drivers
    Table 12. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
    Table 13. Age-Related Macular Degeneration (AMD) Therapeutics Market Restraints
    Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Age-Related Macular Degeneration (AMD) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2023)
    Table 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Product and Application
    Table 21. Global Key Players of Age-Related Macular Degeneration (AMD) Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Age-Related Macular Degeneration (AMD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Age-Related Macular Degeneration (AMD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Age-Related Macular Degeneration (AMD) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Amgen Inc. Company Details
    Table 64. Amgen Inc. Business Overview
    Table 65. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
    Table 66. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Amgen Inc. Recent Developments
    Table 68. Bausch Health Companies, Inc. Company Details
    Table 69. Bausch Health Companies, Inc. Business Overview
    Table 70. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
    Table 71. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Bausch Health Companies, Inc. Recent Developments
    Table 73. F. Hoffmann-La Roche Ltd. Company Details
    Table 74. F. Hoffmann-La Roche Ltd. Business Overview
    Table 75. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product
    Table 76. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 78. Novartis AG Company Details
    Table 79. Novartis AG Business Overview
    Table 80. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product
    Table 81. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Novartis AG Recent Developments
    Table 83. Regeneron Pharmaceuticals Inc. Company Details
    Table 84. Regeneron Pharmaceuticals Inc. Business Overview
    Table 85. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product
    Table 86. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Regeneron Pharmaceuticals Inc. Recent Developments
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Wet AMD Features
    Figure 4. Dry AMD Features
    Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Research Institute Case Studies
    Figure 10. Other Case Studies
    Figure 11. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
    Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2023
    Figure 18. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
    Figure 20. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
    Figure 21. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2019-2030)
    Figure 22. United States Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
    Figure 26. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
    Figure 27. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2019-2030)
    Figure 28. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
    Figure 36. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
    Figure 37. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
    Figure 39. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Region (2019-2030)
    Figure 41. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Country (2019-2030)
    Figure 51. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
    Figure 58. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
    Figure 59. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
    Figure 60. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
    Figure 61. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions